C57BL6 mice were grafted with GL261-Dsred gliomas cells. One week after graft, 20 mg/ml of SMg was intra-veneously injected. treatment was performed once a week.
Trialstreamer annotated collection of RCTs. This respository contains baseline files (large), and subsequent updates (daily for PubMed, weekly for ICTRP).
ABSTRACT Many factors can interfere with glycemic control in patients with type 2 diabetes mellitus and this patient group has an increased risk of experiencing drug-related negative outcomes (DNO). T
